South Korea's PharmaResearch BIO Readies to Boost Exports

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Amid growing domestic sales and exports, PharmaResearch BIO (Seongnam, South Korea), a producer specializing in botulinum toxin, aims to expand one of its major facilities to increase production.

PharmaResearch Bio has continued to grow every year after building its first plant in Gangneung Science Industrial Complex. The company recently secured permission to reach overseas markets, such as China and Europe. Its second plant, which will be built near its existing plant site, its expected to cost more than 20 billion won (US$21.27 million). Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project and Plant databases can learn more from a detailed project report and plant profile.

Subscribers can click here for a full list of detailed project reports for more than US$1 billion in aseptic fill-and-finish projects across South Korea, and click here for a list of related plant profiles.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) platform helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 trillion (USD).